联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20150807 | --- | --- | --- | --- | --- | |-----------------------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------|------------------------------------------|--------| | | | | | | | 投资者关系活动类别 | □特定对象调研 | □分析师会议 | | | | | | □媒体采访 □业绩说明会 | | | | | | □新闻发布会 □路演活动 | | | | | | □现场参观 √其他（台湾机构投资者电话会议） | | | | 参与单位名称及人员 姓名 | 国泰证券 叶岦升 南山人寿 谢尚蓉 | | 练静彤 群益投信 洪玉婷 ...

Group 1: Project Updates - The Yancheng Lianhua project received government approval for trial production in March 2015 and is currently in normal production and sales, generating expected benefits [1] - Other projects are actively seeking approval, but the timeline for trial production permits is uncertain [1] Group 2: Safety and Environmental Concerns - The company emphasizes the importance of safety in the production of phosgene, a toxic gas, and has heightened safety awareness following the Tianjin hazardous chemical explosion [1][2] - The company is committed to strict adherence to environmental laws and regulations, implementing proactive measures to reduce pollution and enhance environmental protection as a core competitive advantage [2][3] Group 3: Management and Talent Acquisition - The addition of Mr. Andreas, with experience in multinational companies, is expected to enhance the company's management in areas such as R&D, quality control, and supply chain management [2] - The company plans to recruit more international talent to further its globalization efforts [2] Group 4: Business Performance and Outlook - The pharmaceutical and intermediate business, while currently small, has a stable profit model and sufficient product pipeline for future revenue [2] - The company expects a net profit growth of 10%-30% for the first nine months of 2015 compared to the same period last year [3] - Currency fluctuations, particularly the depreciation of the RMB, are anticipated to have a positive impact on the company's performance due to its primary business being export-oriented [2]

Group 1: Company Overview and Leadership - The new executive Andreas has joined the company to enhance its pharmaceutical and pharmaceutical intermediate business development [1][2] - The company has established strong partnerships with major international pharmaceutical companies, providing opportunities for growth [2][3] Group 2: Business Growth and Strategy - The company anticipates stable growth in its pesticide and pesticide intermediate business over the next 3 to 5 years [2][4] - The company is exploring mergers and acquisitions as part of its 2020 strategic plan, focusing on both pesticide and pharmaceutical sectors [2][3] Group 3: Service Offerings and Market Position - The company provides two types of services: customized product services and new service models, including R&D services [2][4] - The company positions itself as a leading CMO (Contract Manufacturing Organization) with a strong reputation in both domestic and international markets [4][5] Group 4: Market Dynamics and Challenges - The expiration of patents in the pharmaceutical industry is expected to have a significant price impact but limited quantity impact on the market [4][5] - The company is aware of the competitive landscape and aims to leverage its experience in pesticide production to enhance its pharmaceutical capabilities [4][5] Group 5: Environmental and Safety Investments - The company invested over 100 million in environmental protection in 2014, emphasizing the importance of sustainable development [5]

联化科技股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------|-----------------------------------------------------|--------|--------|-------|--------|---------------------|---------------------------|---------------|----------|--------|--------| | 证券代码： \n投资者关系活动类别 | 002250 \n□特定对象调研 | | | | | □分析师会议 | 证券简称：联化科技 编号： | | 20151028 | | | | | □媒体采访 □业绩说明会 | | | | | | | | | | | | | □新闻发布会 □路演活动 | | | | | | | | | | | | | □现场参观 √其他（投资者交流会--公司事业部发 ...

Group 1: Company Operations and Financial Goals - Taizhou Lianhua's three fundraising projects began trial production and sales in October 2014, with a revenue target of 200 million yuan for the year [1] - The second phase of the multifunctional workshop is designed by a foreign professional company and is expected to be completed and operational by October 2015 [1] - Yancheng Lianhua's first project faced delays in trial production due to environmental approval restrictions, with plans to obtain trial production permits by the end of November 2014 [1] Group 2: Regional Developments - Dezhou Lianhua's first phase covers over 200 acres and is operational, with the second phase design optimization planned to start construction after the Spring Festival [2] - Dezhou Lianhua's revenue is expected to grow compared to the previous year, with significant investments in safety facilities and systems [2] - Tianyu Chemical did not meet its performance targets in the first half of the year due to management and resource allocation issues, but adjustments have been made for better performance in the second half [2] Group 3: Competitive Advantages and Growth Strategy - The company's main competitive advantages lie in speed, service, quality, and flexibility, alongside ongoing technical upgrades and lean production management [2] - The company is open to mergers and acquisitions if they align with its strategic goals and product offerings [2]

联化科技股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | --- | |--------------------|----------------------------------------------|-------------------------------|-----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|------------------| | 证券代码： 002250 | | 证券简称：联化科技 | | 编号：20150428 | | | 投资者关系活动类别 | | | √特定对象调研 □分析师会议 | | | | | | | □媒体采访 □业绩说明会 | | | | | | | □新闻发布会 □路演活动 | | | | | | | | □现场 ...

联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20150528 | --- | --- | --- | --- | |-------------------------|--------------------------------------|-------------|----------------------------------------------------------------| | | | | | | 投资者关系活动类别 | √特定对象调研 | □分析师会议 | | | | □媒体采访 □业绩说明会 | | | | | □新闻发布会 □路演活动 | | | | | | | □现场参观 □其他（投资者接待日活动） | | 参与单位名称及人员 姓名 | 首域投资(香港)有限公司 柯雷 陈希骅 | | | | 时间 | 2015 年 05 月 28 日 | | | | 地点 黄岩 | | | | | 上市公司接待人员姓 名 | 高级副总裁/董秘/财务总监 | | 陈飞彪 证券事务代表 任安立 | | 投资者关系活动主要 | 1. | | 公司的 ...

联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20150313 | --- | --- | --- | --- | --- | --- | |-------------------------|------------------------------------|----------------|--------|------------------------------------------|-----------------------------------------------------------------------------------------------------------| | | | | | | | | 投资者关系活动类别 | | | | √特定对象调研 □分析师会议 | | | | | | | □媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | | | | | | | □现场参观 □其他（投资者接待日活动） | | | 参与单位名称及人员 姓名 | 国泰投信 江宏儒、蔡佩芬 | | | ...

联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20150619 | --- | --- | --- | --- | --- | |-----------------------------|-------------------------------------------------------------------------------|-------------|---------------------|--------------------------------------------------------------| | | | | | | | 投资者关系活动类别 | √特定对象调研 | □分析师会议 | | | | | □媒体采访 □业绩说明会 | | | | | | □新闻发布会 □路演活动 | | | | | | □现场参观 □其他（投资者接待日活动） | | | | | 参与单位名称及人员 姓名 | 平安证券 郭哲 北京睿谷投资 | | | 叶侃 | | 时间 | 2015 年 06 月 19 日 | | | | | 地点 黄岩 ...

联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20160812 | --- | --- | --- | --- | --- | |--------------------|---------------------------------------|------------------------------|---------------------|----------------------------------------------------------------| | | | | | | | 投资者关系活动类别 | □特定对象调研 □媒体采访 □业绩说明会 | □分析师会议 | | | | | □新闻发布会 □路演活动 | | | | | | □现场参观 √其他（投资者接待日活动） | | | | | 参与单位名称及人员 | 详见附件清单 | | | | | 姓名 | | | | | | 时间 | 2016 年 08 月 12 日 | | | | | 地点 黄岩 | | | | | | 上市公司接待人员姓 | 董事长/总裁 王萍 | 董事/ | ...